![Page 1: KUMC Quality Assurance Program for Human Research Karen Blackwell, MS, CIP Director, Human Research Protection Program](https://reader035.vdocuments.net/reader035/viewer/2022070308/551bfdad550346b24f8b4a81/html5/thumbnails/1.jpg)
KUMC Quality Assurance Program for
Human Research
Karen Blackwell, MS, CIP
Director, Human Research Protection Program
![Page 2: KUMC Quality Assurance Program for Human Research Karen Blackwell, MS, CIP Director, Human Research Protection Program](https://reader035.vdocuments.net/reader035/viewer/2022070308/551bfdad550346b24f8b4a81/html5/thumbnails/2.jpg)
Overview
Rationale for proposing a QA program
Activities of the QA Task Force
Task Force recommendations
Next steps
![Page 3: KUMC Quality Assurance Program for Human Research Karen Blackwell, MS, CIP Director, Human Research Protection Program](https://reader035.vdocuments.net/reader035/viewer/2022070308/551bfdad550346b24f8b4a81/html5/thumbnails/3.jpg)
Quality Assurance…
Support and education for investigators Routine on-site reviews of study records Preparation for external audits For-cause audits, when required Feedback to the overall HRPP
![Page 4: KUMC Quality Assurance Program for Human Research Karen Blackwell, MS, CIP Director, Human Research Protection Program](https://reader035.vdocuments.net/reader035/viewer/2022070308/551bfdad550346b24f8b4a81/html5/thumbnails/4.jpg)
Rationale for a QA Program
Reflect our commitment to excellence Coordinate efforts within KUMC Prevent compliance violations Meet contractual and fiduciary duties Address known challenges
![Page 5: KUMC Quality Assurance Program for Human Research Karen Blackwell, MS, CIP Director, Human Research Protection Program](https://reader035.vdocuments.net/reader035/viewer/2022070308/551bfdad550346b24f8b4a81/html5/thumbnails/5.jpg)
EVC’s Charge to the Task Force
Examine model programs Identify key individuals and groups Optimize existing resources Develop standard operating procedures Establish reporting paths Develop a communication plan Report back by September 1st
![Page 6: KUMC Quality Assurance Program for Human Research Karen Blackwell, MS, CIP Director, Human Research Protection Program](https://reader035.vdocuments.net/reader035/viewer/2022070308/551bfdad550346b24f8b4a81/html5/thumbnails/6.jpg)
QA Task Force MembersApril –August 2009
Ed Phillips Jeff Reene Paul Terranova Marge Bott Gary Doolittle Patty Kluding Greg Kopf
Karen Blackwell
Jo Denton Diana Naser Becky Hubbell Monica
Lubeck
![Page 7: KUMC Quality Assurance Program for Human Research Karen Blackwell, MS, CIP Director, Human Research Protection Program](https://reader035.vdocuments.net/reader035/viewer/2022070308/551bfdad550346b24f8b4a81/html5/thumbnails/7.jpg)
Model Programs University of Pittsburgh Partners HealthCare System University of Michigan Emory University Indiana University University of California – San Francisco Baylor College of Medicine Children’s Hospital of Boston
![Page 8: KUMC Quality Assurance Program for Human Research Karen Blackwell, MS, CIP Director, Human Research Protection Program](https://reader035.vdocuments.net/reader035/viewer/2022070308/551bfdad550346b24f8b4a81/html5/thumbnails/8.jpg)
Task Force Recommendations
Overall philosophy for our program
Key components of a QA program
Resources, milestones, timelines
Leadership and oversight
![Page 9: KUMC Quality Assurance Program for Human Research Karen Blackwell, MS, CIP Director, Human Research Protection Program](https://reader035.vdocuments.net/reader035/viewer/2022070308/551bfdad550346b24f8b4a81/html5/thumbnails/9.jpg)
Key Components Support from institutional leadership Clear delineation of roles Transparent criteria for study selection Standard operating procedures Lines of authority to report audit findings Methods to translate findings into
education and support for investigators
![Page 10: KUMC Quality Assurance Program for Human Research Karen Blackwell, MS, CIP Director, Human Research Protection Program](https://reader035.vdocuments.net/reader035/viewer/2022070308/551bfdad550346b24f8b4a81/html5/thumbnails/10.jpg)
Philosophy of the QA Program
Partnership
Focus on education and assistance
Collegial approach
Soliciting investigator feedback
![Page 11: KUMC Quality Assurance Program for Human Research Karen Blackwell, MS, CIP Director, Human Research Protection Program](https://reader035.vdocuments.net/reader035/viewer/2022070308/551bfdad550346b24f8b4a81/html5/thumbnails/11.jpg)
Appendix C
![Page 12: KUMC Quality Assurance Program for Human Research Karen Blackwell, MS, CIP Director, Human Research Protection Program](https://reader035.vdocuments.net/reader035/viewer/2022070308/551bfdad550346b24f8b4a81/html5/thumbnails/12.jpg)
Appendix D
![Page 13: KUMC Quality Assurance Program for Human Research Karen Blackwell, MS, CIP Director, Human Research Protection Program](https://reader035.vdocuments.net/reader035/viewer/2022070308/551bfdad550346b24f8b4a81/html5/thumbnails/13.jpg)
Evaluating ResourcesTarget for
% of studies
reviewed
Routine Reviews per Year
FTEs Annual Routine Reviews per FTE
Team or Single
Institution 1 5% None. Currently
focusing on for-cause
audits
3.5 n/a Teams when needed
Institution 2 2% 1st year: 302nd year: 703rd year: 85
2.3 36 Single reviewer
Institution 3 8% 100 – 110 3.5 and Hiring 2
more FTEs
31 Teams of 2 or 3
Institution 4 10% 200+ 5 40 Single reviewer
![Page 14: KUMC Quality Assurance Program for Human Research Karen Blackwell, MS, CIP Director, Human Research Protection Program](https://reader035.vdocuments.net/reader035/viewer/2022070308/551bfdad550346b24f8b4a81/html5/thumbnails/14.jpg)
Recommended Milestones Aim for 5 – 8% of our 1020 studies 5% = 51 reviews annually; 8% = 81 reviews
1st year 2.5%; 2nd year: 5 – 8%
Minimum staff of 2 FTEs As research volume grows, adjust staff to
maintain the 5 – 8% target
![Page 15: KUMC Quality Assurance Program for Human Research Karen Blackwell, MS, CIP Director, Human Research Protection Program](https://reader035.vdocuments.net/reader035/viewer/2022070308/551bfdad550346b24f8b4a81/html5/thumbnails/15.jpg)
Input and Oversight Model programs recommended ongoing
faculty input Guidance from the Clinical Research
Advisory Committee Oversight by executive leadership:
Vice Chancellor for Administration Vice Chancellor for Research RI Executive Director
![Page 16: KUMC Quality Assurance Program for Human Research Karen Blackwell, MS, CIP Director, Human Research Protection Program](https://reader035.vdocuments.net/reader035/viewer/2022070308/551bfdad550346b24f8b4a81/html5/thumbnails/16.jpg)
Timelines Task Force Report to EVC Presentations to leadership
and investigators Final versions of Standard
Operating Procedures Solicitation of investigators
for voluntary reviews
Program Launch Six-month program
evaluations Annual reports to the EVC
and CRAC
September 2009October – December 2009
November – December 2009
November – December 2009
January 2010
June 2010, Jan 2011, June 2011
January 2011, January 2012
![Page 17: KUMC Quality Assurance Program for Human Research Karen Blackwell, MS, CIP Director, Human Research Protection Program](https://reader035.vdocuments.net/reader035/viewer/2022070308/551bfdad550346b24f8b4a81/html5/thumbnails/17.jpg)
Implementation:Study selectionOn-site reviewFeedbackCorrections as neededTrend analysis
![Page 18: KUMC Quality Assurance Program for Human Research Karen Blackwell, MS, CIP Director, Human Research Protection Program](https://reader035.vdocuments.net/reader035/viewer/2022070308/551bfdad550346b24f8b4a81/html5/thumbnails/18.jpg)
Study SelectionTier 1
Federally or internally funded Moderate to high risk IND/IDE holders KUMC role as coordinating center Vulnerable populations COI
Tier 2 (other studies)
![Page 19: KUMC Quality Assurance Program for Human Research Karen Blackwell, MS, CIP Director, Human Research Protection Program](https://reader035.vdocuments.net/reader035/viewer/2022070308/551bfdad550346b24f8b4a81/html5/thumbnails/19.jpg)
Review Process PI is notified Review is scheduled ~ 2 weeks On-site review
Routine reviews, 20 – 30% of records For-cause, up to 100%
![Page 20: KUMC Quality Assurance Program for Human Research Karen Blackwell, MS, CIP Director, Human Research Protection Program](https://reader035.vdocuments.net/reader035/viewer/2022070308/551bfdad550346b24f8b4a81/html5/thumbnails/20.jpg)
Scope of the Review IRB-approved documents Signed consent forms Study data, e.g.,
Inclusion/exclusion decisions Outcomes of assessments and procedures Source documents
Adverse events or problems Drug/Device accountability
![Page 21: KUMC Quality Assurance Program for Human Research Karen Blackwell, MS, CIP Director, Human Research Protection Program](https://reader035.vdocuments.net/reader035/viewer/2022070308/551bfdad550346b24f8b4a81/html5/thumbnails/21.jpg)
Common Findings at Other Sites
Missing correspondence or approvals Informed consent issues
Expired or invalid consents Not dated or signed correctly Consent by unauthorized persons
Incomplete study records
![Page 22: KUMC Quality Assurance Program for Human Research Karen Blackwell, MS, CIP Director, Human Research Protection Program](https://reader035.vdocuments.net/reader035/viewer/2022070308/551bfdad550346b24f8b4a81/html5/thumbnails/22.jpg)
Serious Findings
Protocol non-compliance Inadequate study records Unreported adverse events or deviations Lack of drug/device accountability Unapproved research
![Page 23: KUMC Quality Assurance Program for Human Research Karen Blackwell, MS, CIP Director, Human Research Protection Program](https://reader035.vdocuments.net/reader035/viewer/2022070308/551bfdad550346b24f8b4a81/html5/thumbnails/23.jpg)
Observations and Corrections
Exit interview Draft report to the PI, within 7 days PI responds with corrections of errors,
clarifications, corrective action plan (if needed), within 14 days
Final report to the PI and to the HSC
![Page 24: KUMC Quality Assurance Program for Human Research Karen Blackwell, MS, CIP Director, Human Research Protection Program](https://reader035.vdocuments.net/reader035/viewer/2022070308/551bfdad550346b24f8b4a81/html5/thumbnails/24.jpg)
Reporting Findings
All final reports go to the HSC office Minor non-compliance is reviewed by the
chair Potentially serious non-compliance goes
to the convened HSC Evaluate corrective action plans Follow-up as appropriate
![Page 25: KUMC Quality Assurance Program for Human Research Karen Blackwell, MS, CIP Director, Human Research Protection Program](https://reader035.vdocuments.net/reader035/viewer/2022070308/551bfdad550346b24f8b4a81/html5/thumbnails/25.jpg)
Getting Feedback
Exit interviews Survey to investigators Input from the CRAC Cumulative results impact overall
program
![Page 26: KUMC Quality Assurance Program for Human Research Karen Blackwell, MS, CIP Director, Human Research Protection Program](https://reader035.vdocuments.net/reader035/viewer/2022070308/551bfdad550346b24f8b4a81/html5/thumbnails/26.jpg)
Feedback?
Questions?